Cargando…

C9orf142 transcriptionally activates MTBP to drive progression and resistance to CDK4/6 inhibitor in triple‐negative breast cancer

BACKGROUND: Triple‐negative breast cancer (TNBC) presents the most challenging subtype of all breast cancers because of its aggressive clinical phenotypes and absence of viable therapy targets. In order to identify effective molecular targets for treating patients with TNBC, we conducted an integrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Li, Deng, Ling, Zhang, Yin‐Ling, Yang, Shao‐Ying, Andriani, Lisa, Hu, Shu‐Yuan, Zhang, Fang‐Lin, Shao, Zhi‐Min, Li, Da‐Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679971/ https://www.ncbi.nlm.nih.gov/pubmed/38009308 http://dx.doi.org/10.1002/ctm2.1480

Ejemplares similares

Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer
por: Liao, Li, et al.
Publicado: (2023)

Chromatin complexes subunit BAP18 promotes triple-negative breast cancer progression through transcriptional activation of oncogene S100A9
por: Zhang, Yin-Ling, et al.
Publicado: (2022)

ETHE1 Accelerates Triple-Negative Breast Cancer Metastasis by Activating GCN2/eIF2α/ATF4 Signaling
por: Yang, Shao-Ying, et al.
Publicado: (2023)

MTBP phosphorylation controls DNA replication origin firing
por: Ferreira, Pedro, et al.
Publicado: (2021)

The Role of MTBP as a Replication Origin Firing Factor
por: Zaffar, Eman, et al.
Publicado: (2022)

MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas
por: Song, Yifu, et al.
Publicado: (2019)

orf6 and orf10 in Prophage phiv142-3 Enhance the Iron-Acquisition Ability and Resistance of Avian Pathogenic Escherichia coli Strain DE142 to Serum
por: Li, Dezhi, et al.
Publicado: (2020)

Deubiquitylase YOD1 regulates CDK1 stability and drives triple-negative breast cancer tumorigenesis
por: Han, Zhitao, et al.
Publicado: (2023)

Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer
por: Zhang, Fang-Lin, et al.
Publicado: (2023)

MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging
por: Grieb, Brian C., et al.
Publicado: (2022)

MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cells
por: Wang, Hongbo, et al.
Publicado: (2022)

MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4
por: Agarwal, Neeraj, et al.
Publicado: (2012)

XLS (c9orf142) is a new component of mammalian DNA double-stranded break repair
por: Craxton, A, et al.
Publicado: (2015)

CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
por: Nie, Lei, et al.
Publicado: (2019)

Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer
por: Zhu, Xiuzhi, et al.
Publicado: (2021)

Inositol monophosphatase 1 (IMPA1) promotes triple‐negative breast cancer progression through regulating mTOR pathway and EMT process
por: Yang, Shao‐Ying, et al.
Publicado: (2022)

MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma
por: Ranjan, Atul, et al.
Publicado: (2018)

The TRESLIN-MTBP complex couples completion of DNA replication with S/G2 transition
por: Zonderland, Gijs, et al.
Publicado: (2022)

Characterization of an Mtbp Hypomorphic Allele in a Diethylnitrosamine-Induced Liver Carcinogenesis Model
por: Ranjan, Atul, et al.
Publicado: (2023)

Prevalence Study of PD-L1 SP142 Assay in Metastatic Triple-negative Breast Cancer
por: Li, Yijin, et al.
Publicado: (2021)

Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
por: Nie, Lei, et al.
Publicado: (2020)

Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer
por: Lian, Bi, et al.
Publicado: (2020)

Haploinsufficiency of the Myc regulator Mtbp extends survival and delays tumor development in aging mice
por: Grieb, Brian C., et al.
Publicado: (2016)

The role of DDK and Treslin–MTBP in coordinating replication licensing and pre-initiation complex formation
por: Volpi, Ilaria, et al.
Publicado: (2021)

Cdk5 phosphorylation‐dependent C9orf72 degradation promotes neuronal death in Parkinson's disease models
por: Xu, Xingfeng, et al.
Publicado: (2023)

CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1
por: Li, Xiao, et al.
Publicado: (2022)

Potential Prospect of CDK4/6 Inhibitors in Triple-Negative Breast Cancer
por: Hu, Ye, et al.
Publicado: (2021)

Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2021)

Binding of the Treslin-MTBP Complex to Specific Regions of the Human Genome Promotes the Initiation of DNA Replication
por: Kumagai, Akiko, et al.
Publicado: (2020)

MTBP promoted the proliferation, migration and invasion of colon cancer cells by activating the expression of ZEB2
por: Shayimu, Paerhati, et al.
Publicado: (2021)

C9orf16 represents the aberrant genetic programs and drives the progression of PDAC
por: Chen, Xiaojun, et al.
Publicado: (2022)

MTBP promotes migration and invasion by regulation of ZEB2-mediated epithelial–mesenchymal transition in lung cancer cells
por: Pan, Bo, et al.
Publicado: (2018)

Inhibition of the CDK9–cyclin T1 protein–protein interaction as a new approach against triple-negative breast cancer
por: Cheng, Sha-Sha, et al.
Publicado: (2022)

Destabilization of microrchidia family CW‐type zinc finger 2 via the cyclin‐dependent kinase 1‐chaperone‐mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule‐targeting agents
por: Hu, Shu‐Yuan, et al.
Publicado: (2023)

Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression
por: Yang, Yun-Song, et al.
Publicado: (2022)

Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer
por: Brisard, Daphne, et al.
Publicado: (2018)

Improvement of therapeutic effects of mesenchymal stem cells in myocardial infarction through genetic suppression of microRNA-142
por: Yang, Liu-Xue, et al.
Publicado: (2017)

Whole genome sequencing identifies missense mutation in MTBP in Shar-Pei affected with Autoinflammatory Disease (SPAID)
por: Metzger, Julia, et al.
Publicado: (2017)

Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
por: Wang, Ruo-Xi, et al.
Publicado: (2018)

Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers
por: Wang, Lei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_prdhjtgitsmr6r582fqg7okldc